Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | endothelin receptor type B | Starlite/ChEMBL | No references |
Mus musculus | endothelin receptor type A | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | hypothetical protein | 0.0508 | 0.2552 | 0.2115 |
Brugia malayi | Eukaryotic-type carbonic anhydrase family protein | 0.0733 | 0.3865 | 0.3211 |
Schistosoma mansoni | carbonic anhydrase II (carbonate dehydratase II) | 0.1784 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.1331 | 0.7354 | 0.7072 |
Schistosoma mansoni | carbonic anhydrase II (carbonate dehydratase II) | 0.1784 | 1 | 1 |
Echinococcus granulosus | alkaline phosphatase intestinal gene 2 | 0.032 | 0.1451 | 0.1451 |
Entamoeba histolytica | carbonic anhydrase, putative | 0.1202 | 0.66 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0733 | 0.3865 | 0.3505 |
Trypanosoma brucei | carbonic anhydrase-like protein | 0.1784 | 1 | 0.5 |
Echinococcus granulosus | carbonic anhydrase | 0.0733 | 0.3865 | 0.3865 |
Echinococcus multilocularis | carbonic anhydrase | 0.0733 | 0.3865 | 0.3211 |
Schistosoma mansoni | carbonic anhydrase-related | 0.0733 | 0.3865 | 0.3505 |
Trichomonas vaginalis | conserved hypothetical protein | 0.1531 | 0.8523 | 0.5 |
Loa Loa (eye worm) | eukaryotic-type carbonic anhydrase | 0.0733 | 0.3865 | 0.3211 |
Echinococcus granulosus | intestinal type alkaline phosphatase | 0.032 | 0.1451 | 0.1451 |
Echinococcus granulosus | carbonic anhydrase | 0.0733 | 0.3865 | 0.3865 |
Echinococcus granulosus | intestinal type alkaline phosphatase 1 | 0.032 | 0.1451 | 0.1451 |
Brugia malayi | Carbonic anhydrase like protein 2 precursor | 0.0733 | 0.3865 | 0.3211 |
Loa Loa (eye worm) | eukaryotic-type carbonic anhydrase | 0.1784 | 1 | 1 |
Schistosoma mansoni | carbonic anhydrase-related | 0.0733 | 0.3865 | 0.3505 |
Mycobacterium tuberculosis | Beta-carbonic anhydrase | 0.0983 | 0.5324 | 1 |
Brugia malayi | Carbonic anhydrase like protein 2 precursor | 0.0733 | 0.3865 | 0.3211 |
Echinococcus granulosus | carbonic anhydrase | 0.0733 | 0.3865 | 0.3865 |
Wolbachia endosymbiont of Brugia malayi | 2,3,4,5-tetrahydropyridine-2,6-carboxylate N-succinyltransferase | 0.0071 | 0 | 0.5 |
Schistosoma mansoni | alkaline phosphatase | 0.032 | 0.1451 | 0.0949 |
Echinococcus multilocularis | intestinal type alkaline phosphatase 1 | 0.032 | 0.1451 | 0.0539 |
Echinococcus multilocularis | intestinal type alkaline phosphatase | 0.032 | 0.1451 | 0.0539 |
Schistosoma mansoni | hypothetical protein | 0.0508 | 0.2552 | 0.2115 |
Trypanosoma cruzi | carbonic anhydrase-like protein, putative | 0.1784 | 1 | 0.5 |
Echinococcus multilocularis | alkaline phosphatase, intestinal, gene 2 | 0.032 | 0.1451 | 0.0539 |
Mycobacterium tuberculosis | Beta-carbonic anhydrase CanB | 0.0654 | 0.3402 | 0.6389 |
Plasmodium falciparum | carbonic anhydrase | 0.0733 | 0.3865 | 0.5 |
Schistosoma mansoni | carbonic anhydrase | 0.1202 | 0.66 | 0.6401 |
Schistosoma mansoni | carbonic anhydrase-related | 0.0733 | 0.3865 | 0.3505 |
Schistosoma mansoni | carbonic anhydrase | 0.0733 | 0.3865 | 0.3505 |
Echinococcus granulosus | geminin | 0.0508 | 0.2552 | 0.2552 |
Leishmania major | carbonic anhydrase-like protein | 0.1784 | 1 | 1 |
Echinococcus multilocularis | carbonic anhydrase | 0.0733 | 0.3865 | 0.3211 |
Mycobacterium ulcerans | carbonic anhydrase | 0.1531 | 0.8523 | 1 |
Echinococcus multilocularis | alkaline phosphatase | 0.032 | 0.1451 | 0.0539 |
Toxoplasma gondii | hypothetical protein | 0.0733 | 0.3865 | 0.5 |
Mycobacterium tuberculosis | Probable transmembrane carbonic anhydrase (carbonate dehydratase) (carbonic dehydratase) | 0.0786 | 0.4175 | 0.7843 |
Trypanosoma cruzi | carbonic anhydrase-like protein, putative | 0.1784 | 1 | 0.5 |
Echinococcus multilocularis | carbonic anhydrase II | 0.1784 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0733 | 0.3865 | 0.3211 |
Loa Loa (eye worm) | carbonic anhydrase 3 | 0.1784 | 1 | 1 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0236 | 0.0964 | 0.0964 |
Schistosoma mansoni | alkaline phosphatase | 0.032 | 0.1451 | 0.0949 |
Echinococcus granulosus | carbonic anhydrase II | 0.1784 | 1 | 1 |
Onchocerca volvulus | 0.0206 | 0.079 | 0.5 | |
Mycobacterium tuberculosis | Probable conserved transmembrane protein | 0.0238 | 0.0977 | 0.1835 |
Echinococcus granulosus | alkaline phosphatase | 0.032 | 0.1451 | 0.1451 |
Trichomonas vaginalis | conserved hypothetical protein | 0.1531 | 0.8523 | 0.5 |
Brugia malayi | Putative carbonic anhydrase 5 precursor | 0.1784 | 1 | 1 |
Echinococcus multilocularis | geminin | 0.0508 | 0.2552 | 0.1758 |
Brugia malayi | Eukaryotic-type carbonic anhydrase family protein | 0.0733 | 0.3865 | 0.3211 |
Wolbachia endosymbiont of Brugia malayi | N-acetylglucosamine-1-phosphate uridyltransferase | 0.0071 | 0 | 0.5 |
Echinococcus multilocularis | carbonic anhydrase | 0.0733 | 0.3865 | 0.3211 |
Onchocerca volvulus | Putative sulfate transporter | 0.0206 | 0.079 | 0.5 |
Brugia malayi | Eukaryotic-type carbonic anhydrase family protein | 0.0733 | 0.3865 | 0.3211 |
Loa Loa (eye worm) | hypothetical protein | 0.0733 | 0.3865 | 0.3211 |
Mycobacterium leprae | CARBONIC ANHYDRASE (CARBONATE DEHYDRATASE) (CARBONIC DEHYDRATASE) | 0.1202 | 0.66 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 15 nM | The inhibitory constant of the compound was evaluated against Endothelin A receptor | ChEMBL. | No reference |
IC50 (binding) | = 15 nM | The inhibitory constant of the compound was evaluated against Endothelin A receptor | ChEMBL. | No reference |
IC50 (binding) | = 45 nM | Inhibition of [125I]-ET-1 binding to Endothelin A receptor of murine 3T3 cells | ChEMBL. | No reference |
IC50 (binding) | = 45 nM | Inhibition of [125I]-ET-1 binding to Endothelin A receptor of murine 3T3 cells | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.